Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.0100141 | 0.0493197 | 0.589461 |
Loa Loa (eye worm) | hypothetical protein | 0.0100141 | 0.0493197 | 0.589461 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.00666456 | 0.0104463 | 0.5 |
Mycobacterium leprae | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0455288 | 0.461495 | 0.5 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.00681408 | 0.0121816 | 0.134445 |
Schistosoma mansoni | tyrosine kinase | 0.00586857 | 0.00120825 | 0.0145875 |
Echinococcus multilocularis | bifunctional polynucleotide | 0.00666456 | 0.0104463 | 0.113184 |
Brugia malayi | DNA 3'-phosphatase family protein | 0.00666456 | 0.0104463 | 0.113184 |
Schistosoma mansoni | polynucleotide kinase-3'-phosphatase | 0.00666456 | 0.0104463 | 0.126121 |
Loa Loa (eye worm) | hypothetical protein | 0.00666456 | 0.0104463 | 0.113184 |
Echinococcus granulosus | insulin receptor | 0.0129013 | 0.0828278 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.00666456 | 0.0104463 | 0.5 |
Mycobacterium ulcerans | imidazoleglycerol-phosphate dehydratase | 0.0919286 | 1 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0129013 | 0.0828278 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.00681408 | 0.0121816 | 0.147071 |
Entamoeba histolytica | polynucleotide kinase-3-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0129013 | 0.0828278 | 1 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.00813435 | 0.0275043 | 0.322179 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0129013 | 0.0828278 | 1 |
Trypanosoma cruzi | polynucleotide kinase 3'-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Mycobacterium tuberculosis | Probable imidazole glycerol-phosphate dehydratase HisB | 0.0919286 | 1 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0129013 | 0.0828278 | 1 |
Plasmodium vivax | bifunctional polynucleotide phosphatase/kinase, putative | 0.00666456 | 0.0104463 | 0.5 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.0100141 | 0.0493197 | 0.589461 |
Loa Loa (eye worm) | hypothetical protein | 0.00703267 | 0.0147185 | 0.165527 |
Plasmodium vivax | phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Plasmodium falciparum | bifunctional polynucleotide phosphatase/kinase | 0.00666456 | 0.0104463 | 0.5 |
Echinococcus granulosus | bifunctional polynucleotide | 0.00666456 | 0.0104463 | 0.113184 |
Plasmodium falciparum | phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.00586857 | 0.00120825 | 0.0145875 |
Schistosoma mansoni | tyrosine kinase | 0.0129013 | 0.0828278 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.00586857 | 0.00120825 | 0.0145875 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.00681408 | 0.0121816 | 0.134445 |
Trypanosoma cruzi | polynucleotide kinase 3'-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Echinococcus multilocularis | insulin receptor | 0.0129013 | 0.0828278 | 1 |
Onchocerca volvulus | Bifunctional polynucleotide phosphatase\/kinase homolog | 0.00666456 | 0.0104463 | 0.5 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.00924921 | 0.0404431 | 0.48828 |
Trypanosoma brucei | polynucleotide kinase 3'-phosphatase, putative | 0.00666456 | 0.0104463 | 0.5 |
Loa Loa (eye worm) | glutamate receptor | 0.00813435 | 0.0275043 | 0.322179 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0129013 | 0.0828278 | 1 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.00736951 | 0.0186277 | 0.213423 |
Brugia malayi | Protein kinase domain containing protein | 0.00713678 | 0.0159268 | 0.180331 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0.09 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as parasitized red blood cells level at 100 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection measured on day 4 (Rvb = 78%) | ChEMBL. | 21875063 |
Activity (functional) | = 0.3 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as parasitized red blood cells level at 30 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection measured on day 4 (Rvb = 78%) | ChEMBL. | 21875063 |
Activity (functional) | = 99.6 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as reduction of parasitemia level at 30 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 0.38%) | ChEMBL. | 21875063 |
Activity (functional) | = 99.9 % | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as reduction of parasitemia level at 100 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 0.12%) | ChEMBL. | 21875063 |
IC50 (functional) | = 140 nM | Antimalarial activity against erythrocyte stages of chloroquine-sensitive Plasmodium falciparum D10 infected in human erythrocytes by lactate dehydrogenase assay | ChEMBL. | 21875063 |
IC50 (binding) | = 58 uM | Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 chloroquine resistance transporter expressed in xenopus laevis oocytes assessed as inhibition of [3H]chloroquine uptake after 1 to 2 hrs | ChEMBL. | 21875063 |
Ratio IC50 (functional) | = 0.9 | Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum D10 | ChEMBL. | 21875063 |
Time (functional) | = 20.7 day | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as host survival time at 30 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 4 days) | ChEMBL. | 21875063 |
Time (functional) | = 30 day | Antimalarial activity against Plasmodium berghei infected in NMRI mouse assessed as host survival time at 100 mg/kg, po administered on day 0, 1, 2 and 3 after postinfection (Rvb = 4 days) | ChEMBL. | 21875063 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 21875063 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.